| Year |
Citation |
Score |
| 2020 |
Werner C, Dirsch O, Dahmen U, Grimm MO, Schulz S, Lupp A. Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies. Translational Oncology. 13: 100801. PMID 32460182 DOI: 10.1016/J.Tranon.2020.100801 |
0.304 |
|
| 2020 |
Mann A, Liebetrau S, Klima M, Dasgupta P, Massotte D, Schulz S. Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies. Scientific Reports. 10: 8585. PMID 32444688 DOI: 10.1038/S41598-020-65589-7 |
0.375 |
|
| 2020 |
Gillis A, Gondin AB, Kliewer A, Sanchez J, Lim HD, Alamein C, Manandhar P, Santiago M, Fritzwanker S, Schmidel F, Katte TA, Reekie T, Grimsey NL, Kassiou M, Kellam B, ... ... Schulz S, et al. Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists. Science Signaling. 13. PMID 32234959 DOI: 10.1126/Scisignal.Aaz3140 |
0.334 |
|
| 2020 |
Kliewer A, Gillis A, Hill R, Schmidel F, Bailey C, Kelly E, Henderson G, Christie MJ, Schulz S. Morphine-induced respiratory depression is independent of ß-arrestin2 signalling. British Journal of Pharmacology. PMID 32052419 DOI: 10.1111/Bph.15004 |
0.303 |
|
| 2019 |
Herzig M, Dasgupta P, Kaemmerer D, Sänger J, Evert K, Schulz S, Lupp A. Comprehensive Assessment of GPR68 Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody. International Journal of Molecular Sciences. 20. PMID 31652823 DOI: 10.3390/Ijms20215261 |
0.301 |
|
| 2019 |
Kajtazi Y, Kaemmerer D, Sänger J, Schulz S, Lupp A. Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours. Journal of Cancer Research and Clinical Oncology. PMID 31451931 DOI: 10.1007/S00432-019-03011-0 |
0.345 |
|
| 2019 |
Nakai A, Fujimoto J, Miyata H, Stumm R, Narazaki M, Schulz S, Baba Y, Kumanogoh A, Suzuki K. The COMMD3/8 complex determines GRK6 specificity for chemoattractant receptors. The Journal of Experimental Medicine. PMID 31088898 DOI: 10.1084/Jem.20181494 |
0.358 |
|
| 2019 |
Mann A, Moulédous L, Froment C, O'Neill PR, Dasgupta P, Günther T, Brunori G, Kieffer BL, Toll L, Bruchas MR, Zaveri NT, Schulz S. Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists. Science Signaling. 12. PMID 30914485 DOI: 10.1126/Scisignal.Aau8072 |
0.39 |
|
| 2019 |
Mai R, Kaemmerer D, Träger T, Neubauer E, Sänger J, Baum RP, Schulz S, Lupp A. Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin. Scientific Reports. 9: 4339. PMID 30867449 DOI: 10.1038/S41598-019-39607-2 |
0.324 |
|
| 2019 |
Saaber F, Schütz D, Miess E, Abe P, Desikan S, Ashok Kumar P, Balk S, Huang K, Beaulieu JM, Schulz S, Stumm R. ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin. Cell Reports. 26: 1473-1488.e9. PMID 30726732 DOI: 10.1016/J.Celrep.2019.01.049 |
0.322 |
|
| 2019 |
Kliewer A, Schmiedel F, Sianati S, Bailey A, Bateman JT, Levitt ES, Williams JT, Christie MJ, Schulz S. Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects. Nature Communications. 10: 367. PMID 30664663 DOI: 10.1038/S41467-018-08162-1 |
0.327 |
|
| 2018 |
Günther T, Tulipano G, Dournaud P, Bousquet C, Csaba Z, Kreienkamp HJ, Lupp A, Korbonits M, Castaño JP, Wester HJ, Culler M, Melmed S, Schulz S. International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature. Pharmacological Reviews. 70: 763-835. PMID 30232095 DOI: 10.1124/Pr.117.015388 |
0.38 |
|
| 2018 |
Miess E, Gondin AB, Yousuf A, Steinborn R, Mösslein N, Yang Y, Göldner M, Ruland JG, Bünemann M, Krasel C, Christie MJ, Halls ML, Schulz S, Canals M. Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization. Science Signaling. 11. PMID 30018083 DOI: 10.1126/Scisignal.Aas9609 |
0.358 |
|
| 2018 |
Lange F, Kaemmerer D, Behnke-Mursch J, Brück W, Schulz S, Lupp A. Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I-IV astrocytic brain tumors. Journal of Cancer Research and Clinical Oncology. PMID 29696364 DOI: 10.1007/S00432-018-2645-1 |
0.302 |
|
| 2017 |
Kaemmerer D, Sänger J, Arsenic R, D'Haese JG, Neumann J, Schmitt-Graeff A, Wirtz RM, Schulz S, Lupp A. Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas. Oncotarget. 8: 89958-89969. PMID 29163802 DOI: 10.18632/Oncotarget.21194 |
0.337 |
|
| 2017 |
Kliewer A, Reinscheid RK, Schulz S. Emerging Paradigms of G Protein-Coupled Receptor Dephosphorylation. Trends in Pharmacological Sciences. PMID 28478994 DOI: 10.1016/J.Tips.2017.04.002 |
0.366 |
|
| 2017 |
Günther T, Dasgupta P, Mann A, Miess E, Kliewer A, Fritzwanker S, Steinborn R, Schulz S. Targeting multiple opioid receptors - improved analgesics with reduced side effects? British Journal of Pharmacology. PMID 28378462 DOI: 10.1111/Bph.13809 |
0.369 |
|
| 2016 |
Stollberg S, Kämmerer D, Neubauer E, Schulz S, Simonitsch-Klupp I, Kiesewetter B, Raderer M, Lupp A. Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin. Journal of Cancer Research and Clinical Oncology. PMID 27544389 DOI: 10.1007/S00432-016-2220-6 |
0.366 |
|
| 2016 |
Lehmann A, Kliewer A, Günther T, Nagel F, Schulz S. Identification of phosphorylation sites regulating sst3 somatostatin receptor trafficking. Molecular Endocrinology (Baltimore, Md.). me20151244. PMID 27101376 DOI: 10.1210/Me.2015-1244 |
0.385 |
|
| 2016 |
Günther T, Culler M, Schulz S. Research Resource: Real-time analysis of somatostatin and dopamine receptor signaling in pituitary cells using a fluorescence-based membrane potential assay. Molecular Endocrinology (Baltimore, Md.). me20151241. PMID 26967369 DOI: 10.1210/Me.2015-1241 |
0.36 |
|
| 2015 |
Mousa SA, Shaqura M, Winkler J, Khalefa BI, Al-Madol MA, Shakibaei M, Schulz S, Schäfer M. Protein kinase C-mediated mu-opioid receptor phosphorylation and desensitization in rats and its prevention during early diabetes. Pain. PMID 26713421 DOI: 10.1097/J.Pain.0000000000000459 |
0.313 |
|
| 2015 |
Kaemmerer D, Träger T, Hoffmeister M, Sipos B, Hommann M, Sänger J, Schulz S, Lupp A. Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy. Oncotarget. 6: 27566-79. PMID 26259237 DOI: 10.18632/Oncotarget.4491 |
0.368 |
|
| 2015 |
Moulédous L, Froment C, Burlet-Schiltz O, Schulz S, Mollereau C. Phosphoproteomic analysis of the mouse brain mu-opioid (MOP) receptor. Febs Letters. 589: 2401-8. PMID 26226422 DOI: 10.1016/J.Febslet.2015.07.025 |
0.338 |
|
| 2015 |
Bowman SL, Soohoo AL, Shiwarski DJ, Schulz S, Pradhan AA, Puthenveedu MA. Cell-autonomous regulation of Mu-opioid receptor recycling by substance P. Cell Reports. 10: 1925-36. PMID 25801029 DOI: 10.1016/J.Celrep.2015.02.045 |
0.353 |
|
| 2015 |
Lupp A, Mann A, Heeb A, Kaemmerer D, Sänger J, Evert M, Evert K, Mawrin C, Schulz S. Reassessment of endothelin receptor A expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-8. Peptides. 66: 19-25. PMID 25708416 DOI: 10.1016/J.Peptides.2015.02.005 |
0.322 |
|
| 2015 |
Ádori C, Glück L, Barde S, Yoshitake T, Kovacs GG, Mulder J, Maglóczky Z, Havas L, Bölcskei K, Mitsios N, Uhlén M, Szolcsányi J, Kehr J, Rönnbäck A, Schwartz T, ... ... Schulz S, et al. Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease. Acta Neuropathologica. 129: 541-63. PMID 25676386 DOI: 10.1007/S00401-015-1394-3 |
0.331 |
|
| 2015 |
Kaemmerer D, Reimann C, Specht E, Wirtz RM, Sayeg M, Baum RP, Schulz S, Lupp A. Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms. Oncotarget. 6: 3346-58. PMID 25671300 DOI: 10.18632/Oncotarget.3242 |
0.33 |
|
| 2015 |
Specht E, Kaemmerer D, Sänger J, Wirtz RM, Schulz S, Lupp A. Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms. Histopathology. PMID 25641082 DOI: 10.1111/His.12662 |
0.314 |
|
| 2015 |
Lee M, Lupp A, Mendoza N, Martin N, Beschorner R, Honegger J, Schlegel J, Shively T, Pulz E, Schulz S, Roncaroli F, Pellegata NS. SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary. Endocrine-Related Cancer. 22: 111-9. PMID 25515731 DOI: 10.1530/Erc-14-0472 |
0.327 |
|
| 2015 |
Schulz S, Mann A, Novakhov B, Piggins HD, Lupp A. VPAC2 receptor expression in human normal and neoplastic tissues: evaluation of the novel MAB SP235. Endocrine Connections. 4: 18-26. PMID 25504760 DOI: 10.1530/Ec-14-0051 |
0.302 |
|
| 2015 |
Kaemmerer D, Specht E, Sänger J, Wirtz RM, Sayeg M, Schulz S, Lupp A. Somatostatin receptors in bronchopulmonary neuroendocrine neoplasms: new diagnostic, prognostic, and therapeutic markers. The Journal of Clinical Endocrinology and Metabolism. 100: 831-40. PMID 25494861 DOI: 10.1210/Jc.2014-2699 |
0.351 |
|
| 2015 |
Mann A, Illing S, Miess E, Schulz S. Different mechanisms of homologous and heterologous μ-opioid receptor phosphorylation. British Journal of Pharmacology. 172: 311-6. PMID 24517854 DOI: 10.1111/Bph.12627 |
0.356 |
|
| 2014 |
Otte M, Kliewer A, Schütz D, Reimann C, Schulz S, Stumm R. CXCL14 is no direct modulator of CXCR4. Febs Letters. 588: 4769-75. PMID 25451233 DOI: 10.1016/J.Febslet.2014.11.009 |
0.321 |
|
| 2014 |
Madishetti S, Schneble N, König C, Hirsch E, Schulz S, Müller JP, Wetzker R. PI3Kγ integrates cAMP and Akt signalling of the μ-opioid receptor. British Journal of Pharmacology. 171: 3328-37. PMID 24654606 DOI: 10.1111/Bph.12698 |
0.339 |
|
| 2014 |
Lehmann A, Kliewer A, Märtens JC, Nagel F, Schulz S. Carboxyl-terminal receptor domains control the differential dephosphorylation of somatostatin receptors by protein phosphatase 1 isoforms. Plos One. 9: e91526. PMID 24637622 DOI: 10.1371/Journal.Pone.0091526 |
0.379 |
|
| 2014 |
Glück L, Loktev A, Moulédous L, Mollereau C, Law PY, Schulz S. Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5. Biological Psychiatry. 76: 767-74. PMID 24629717 DOI: 10.1016/J.Biopsych.2014.01.021 |
0.345 |
|
| 2014 |
Lehmann A, Kliewer A, Schütz D, Nagel F, Stumm R, Schulz S. Carboxyl-terminal multi-site phosphorylation regulates internalization and desensitization of the human sst2 somatostatin receptor. Molecular and Cellular Endocrinology. 387: 44-51. PMID 24565897 DOI: 10.1016/J.Mce.2014.02.009 |
0.323 |
|
| 2014 |
Shi TJ, Xiang Q, Zhang MD, Barde S, Kai-Larsen Y, Fried K, Josephson A, Glück L, Deyev SM, Zvyagin AV, Schulz S, Hökfelt T. Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human: expression, trafficking and possible role in pain. Molecular Pain. 10: 12. PMID 24521084 DOI: 10.1186/1744-8069-10-12 |
0.3 |
|
| 2014 |
Schulz S, Lehmann A, Kliewer A, Nagel F. Fine-tuning somatostatin receptor signalling by agonist-selective phosphorylation and dephosphorylation: IUPHAR Review 5. British Journal of Pharmacology. 171: 1591-9. PMID 24328848 DOI: 10.1111/Bph.12551 |
0.385 |
|
| 2014 |
Illing S, Mann A, Schulz S. Heterologous regulation of agonist-independent μ-opioid receptor phosphorylation by protein kinase C. British Journal of Pharmacology. 171: 1330-40. PMID 24308893 DOI: 10.1111/Bph.12546 |
0.319 |
|
| 2014 |
Kliewer A, Schulz S. Differential regulation of somatostatin receptor dephosphorylation by β-arrestin1 and β-arrestin2. Naunyn-Schmiedeberg's Archives of Pharmacology. 387: 263-9. PMID 24276218 DOI: 10.1007/S00210-013-0939-Z |
0.335 |
|
| 2014 |
Peineau S, Guimiot F, Csaba Z, Jacquier S, Fafouri A, Schwendimann L, de Roux N, Schulz S, Gressens P, Auvin S, Dournaud P. Somatostatin receptors type 2 and 5 expression and localization during human pituitary development. Endocrinology. 155: 33-9. PMID 24189142 DOI: 10.1210/En.2013-1683 |
0.367 |
|
| 2013 |
Lambertini C, Barzaghi-Rinaudo P, D'Amato L, Schulz S, Nuciforo P, Schmid HA. Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies. Regulatory Peptides. 187: 35-41. PMID 24188818 DOI: 10.1016/J.Regpep.2013.10.007 |
0.326 |
|
| 2013 |
Casar-Borota O, Heck A, Schulz S, Nesland JM, Ramm-Pettersen J, Lekva T, Alafuzoff I, Bollerslev J. Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide. The Journal of Clinical Endocrinology and Metabolism. 98: E1730-9. PMID 24092823 DOI: 10.1210/Jc.2013-2145 |
0.321 |
|
| 2013 |
van der Pas R, Feelders RA, Gatto F, de Bruin C, Pereira AM, van Koetsveld PM, Sprij-Mooij DM, Waaijers AM, Dogan F, Schulz S, Kros JM, Lamberts SW, Hofland LJ. Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists. The Journal of Clinical Endocrinology and Metabolism. 98: E1880-90. PMID 24081741 DOI: 10.1210/Jc.2013-1987 |
0.344 |
|
| 2013 |
Lupp A, Nagel F, Schulz S. Reevaluation of sst₁ somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-7. Regulatory Peptides. 183: 1-6. PMID 23466804 DOI: 10.1016/J.Regpep.2013.02.001 |
0.313 |
|
| 2013 |
Petrich A, Mann A, Kliewer A, Nagel F, Strigli A, Märtens JC, Pöll F, Schulz S. Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor. Molecular Endocrinology (Baltimore, Md.). 27: 671-82. PMID 23418396 DOI: 10.1210/Me.2012-1329 |
0.324 |
|
| 2013 |
Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, Koch T, Evans CJ, Christie MJ. Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacological Reviews. 65: 223-54. PMID 23321159 DOI: 10.1124/Pr.112.005942 |
0.336 |
|
| 2013 |
Just S, Illing S, Trester-Zedlitz M, Lau EK, Kotowski SJ, Miess E, Mann A, Doll C, Trinidad JC, Burlingame AL, von Zastrow M, Schulz S. Differentiation of opioid drug effects by hierarchical multi-site phosphorylation. Molecular Pharmacology. 83: 633-9. PMID 23239825 DOI: 10.1124/Mol.112.082875 |
0.323 |
|
| 2013 |
Doll C, Pöll F, Peuker K, Loktev A, Glück L, Schulz S. Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells. British Journal of Pharmacology. 167: 1259-70. PMID 22725608 DOI: 10.1111/J.1476-5381.2012.02080.X |
0.365 |
|
| 2013 |
Lambertini C, Barzaghi-Rinaudo P, D'Amato L, Schulz S, Nuciforo P, Schmid HA. Abstract 92: Comparative expression analysis of somatostatin receptor subtypes in human neuroendocrine tumors using two sets of new monoclonal antibodies. Cancer Research. 73: 92-92. DOI: 10.1158/1538-7445.Am2013-92 |
0.341 |
|
| 2012 |
Unger N, Ueberberg B, Schulz S, Saeger W, Mann K, Petersenn S. Differential expression of somatostatin receptor subtype 1-5 proteins in numerous human normal tissues. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association. 120: 482-9. PMID 22976314 DOI: 10.1055/S-0032-1314859 |
0.349 |
|
| 2012 |
Wang X, Fani M, Schulz S, Rivier J, Reubi JC, Maecke HR. Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy European Journal of Nuclear Medicine and Molecular Imaging. 39: 1876-1885. PMID 22926735 DOI: 10.1007/S00259-012-2231-8 |
0.303 |
|
| 2012 |
Haege S, Einer C, Thiele S, Mueller W, Nietzsche S, Lupp A, Mackay F, Schulz S, Stumm R. CXC chemokine receptor 7 (CXCR7) regulates CXCR4 protein expression and capillary tuft development in mouse kidney. Plos One. 7: e42814. PMID 22880115 DOI: 10.1371/Journal.Pone.0042814 |
0.321 |
|
| 2012 |
Kliewer A, Mann A, Petrich A, Pöll F, Schulz S. A transplantable phosphorylation probe for direct assessment of G protein-coupled receptor activation. Plos One. 7: e39458. PMID 22745760 DOI: 10.1371/Journal.Pone.0039458 |
0.378 |
|
| 2012 |
Hoffmann F, Müller W, Schütz D, Penfold ME, Wong YH, Schulz S, Stumm R. Rapid uptake and degradation of CXCL12 depend on CXCR7 carboxyl-terminal serine/threonine residues. The Journal of Biological Chemistry. 287: 28362-77. PMID 22736769 DOI: 10.1074/Jbc.M111.335679 |
0.328 |
|
| 2012 |
Chahal HS, Trivellin G, Leontiou CA, Alband N, Fowkes RC, Tahir A, Igreja SC, Chapple JP, Jordan S, Lupp A, Schulz S, Ansorge O, Karavitaki N, Carlsen E, Wass JA, et al. Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway. The Journal of Clinical Endocrinology and Metabolism. 97: E1411-20. PMID 22659247 DOI: 10.1210/Jc.2012-1111 |
0.308 |
|
| 2012 |
Müssig K, Wehrmann T, Dittmann H, Wehrmann M, Ueberberg B, Schulz S, Bares R, Petersenn S. Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas. Clinical Endocrinology. 77: 139-145. PMID 22248072 DOI: 10.1111/J.1365-2265.2012.04343.X |
0.314 |
|
| 2012 |
Najib S, Saint-Laurent N, Estève J, Schulz S, Boutet-Robinet E, Fourmy D, Lättig J, Mollereau C, Pyronnet S, Susini C, Bousquet C. A Switch of G Protein-Coupled Receptor Binding Preference from Phosphoinositide 3-Kinase (PI3K)–p85 to Filamin A Negatively Controls the PI3K Pathway Molecular and Cellular Biology. 32: 1004-1016. PMID 22203038 DOI: 10.1128/Mcb.06252-11 |
0.324 |
|
| 2012 |
Gatto F, Barbieri F, Gatti M, Wurth R, Schulz S, Ravetti JL, Zona G, Culler MD, Saveanu A, Giusti M, Minuto F, Hofland LJ, Ferone D, Florio T. Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins. Clinical Endocrinology. 76: 407-14. PMID 21848909 DOI: 10.1111/J.1365-2265.2011.04200.X |
0.301 |
|
| 2011 |
Grecksch G, Just S, Pierstorff C, Imhof AK, Glück L, Doll C, Lupp A, Becker A, Koch T, Stumm R, Höllt V, Schulz S. Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A μ-opioid receptor knock-in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 13890-6. PMID 21957251 DOI: 10.1523/Jneurosci.2304-11.2011 |
0.326 |
|
| 2011 |
Kaemmerer D, Peter L, Lupp A, Schulz S, Sänger J, Prasad V, Kulkarni H, Haugvik SP, Hommann M, Baum RP. Molecular imaging with â¶â¸Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. 38: 1659-68. PMID 21626438 DOI: 10.1007/S00259-011-1846-5 |
0.303 |
|
| 2011 |
Imhof A, Glück L, Gajda M, Lupp A, Bräuer R, Schaible H, Schulz S. Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis. Arthritis & Rheumatism. 63: 2352-2362. PMID 21506098 DOI: 10.1002/Art.30410 |
0.307 |
|
| 2011 |
Doll C, Konietzko J, Pöll F, Koch T, Höllt V, Schulz S. Agonist-selective patterns of µ-opioid receptor phosphorylation revealed by phosphosite-specific antibodies. British Journal of Pharmacology. 164: 298-307. PMID 21449911 DOI: 10.1111/J.1476-5381.2011.01382.X |
0.348 |
|
| 2011 |
Nagel F, Doll C, Pöll F, Kliewer A, Schröder H, Schulz S. Structural Determinants of Agonist-Selective Signaling at the sst2A Somatostatin Receptor Molecular Endocrinology. 25: 859-866. PMID 21330405 DOI: 10.1210/Me.2010-0407 |
0.337 |
|
| 2011 |
Sánchez-Alcañiz JA, Haege S, Mueller W, Pla R, Mackay F, Schulz S, López-Bendito G, Stumm R, MarÃn O. Cxcr7 controls neuronal migration by regulating chemokine responsiveness. Neuron. 69: 77-90. PMID 21220100 DOI: 10.1016/J.Neuron.2010.12.006 |
0.351 |
|
| 2011 |
Lupp A, Richter N, Doll C, Nagel F, Schulz S. UMB-3, a novel rabbit monoclonal antibody, for assessing Μ-opioid receptor expression in mouse, rat and human formalin-fixed and paraffin-embedded tissues Regulatory Peptides. 167: 9-13. PMID 20851148 DOI: 10.1016/J.Regpep.2010.09.004 |
0.332 |
|
| 2010 |
Jacobs S, Calebiro D, Nikolaev VO, Lohse MJ, Schulz S. Real-time monitoring of somatostatin receptor-cAMP signaling in live pituitary. Endocrinology. 151: 4560-5. PMID 20610560 DOI: 10.1210/En.2010-0341 |
0.522 |
|
| 2010 |
König C, Gavrilova-Ruch O, von Banchet GS, Bauer R, Grün M, Hirsch E, Rubio I, Schulz S, Heinemann SH, Schaible HG, Wetzker R. Modulation of mu opioid receptor desensitization in peripheral sensory neurons by phosphoinositide 3-kinase gamma. Neuroscience. 169: 449-54. PMID 20451587 DOI: 10.1016/J.Neuroscience.2010.04.068 |
0.362 |
|
| 2010 |
Lupp A, Klenk C, Röcken C, Evert M, Mawrin C, Schulz S. Immunohistochemical identification of the PTHR1 parathyroid hormone receptor in normal and neoplastic human tissues European Journal of Endocrinology. 162: 979-986. PMID 20156969 DOI: 10.1530/Eje-09-0821 |
0.343 |
|
| 2010 |
Klenk C, Schulz S, Calebiro D, Lohse MJ. Agonist-regulated cleavage of the extracellular domain of parathyroid hormone receptor type 1. The Journal of Biological Chemistry. 285: 8665-74. PMID 20080964 DOI: 10.1074/Jbc.M109.058685 |
0.54 |
|
| 2010 |
Pöll F, Lehmann D, Illing S, Ginj M, Jacobs S, Lupp A, Stumm R, Schulz S. Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation. Molecular Endocrinology (Baltimore, Md.). 24: 436-46. PMID 20051480 DOI: 10.1210/Me.2009-0315 |
0.343 |
|
| 2009 |
Durán-Prado M, Gahete MD, MartÃnez-Fuentes AJ, Luque RM, Quintero A, Webb SM, Benito-López P, Leal A, Schulz S, Gracia-Navarro F, Malagón MM, Castaño JP. Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors. The Journal of Clinical Endocrinology and Metabolism. 94: 2634-43. PMID 19401364 DOI: 10.1210/Jc.2008-2564 |
0.373 |
|
| 2009 |
Schröder H, Wu D-, Seifert A, Rankovic M, Schulz S, Höllt V, Koch T. Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the μ-opioid receptor Neuropharmacology. 56: 768-778. PMID 19162047 DOI: 10.1016/J.Neuropharm.2008.12.010 |
0.369 |
|
| 2009 |
Schmitt JP, Ahmad F, Lorenz K, Hein L, Schulz S, Asahi M, Maclennan DH, Seidman CE, Seidman JG, Lohse MJ. Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition. Circulation. 119: 436-44. PMID 19139388 DOI: 10.1161/Circulationaha.108.783506 |
0.442 |
|
| 2009 |
Lesche S, Lehmann D, Nagel F, Schmid HA, Schulz S. Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro. The Journal of Clinical Endocrinology and Metabolism. 94: 654-61. PMID 19001514 DOI: 10.1210/Jc.2008-1919 |
0.384 |
|
| 2008 |
Fischer T, Nagel F, Jacobs S, Stumm R, Schulz S. Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2. Plos One. 3: e4069. PMID 19116653 DOI: 10.1371/Journal.Pone.0004069 |
0.367 |
|
| 2008 |
Liew CW, Vockel M, Glassmeier G, Brandner JM, Fernandez-Ballester GJ, Schwarz JR, Schulz S, Buck F, Serrano L, Richter D, Kreienkamp HJ. Interaction of the human somatostatin receptor 3 with the multiple PDZ domain protein MUPP1 enables somatostatin to control permeability of epithelial tight junctions. Febs Letters. 583: 49-54. PMID 19071123 DOI: 10.1016/J.Febslet.2008.11.048 |
0.33 |
|
| 2008 |
Cai C, Li H, Kangasniemi A, Pihlajamaa T, Von Ossowski L, Kerkelä K, Schulz S, Rivera C, Keinänen K. Somatostatin receptor subtype 1 is a PDZ ligand for synapse-associated protein 97 and a potential regulator of growth cone dynamics. Neuroscience. 157: 833-43. PMID 18951956 DOI: 10.1016/J.Neuroscience.2008.09.048 |
0.324 |
|
| 2008 |
Schönemeier B, Kolodziej A, Schulz S, Jacobs S, Hoellt V, Stumm R. Regional and cellular localization of the CXCl12/SDF-1 chemokine receptor CXCR7 in the developing and adult rat brain. The Journal of Comparative Neurology. 510: 207-20. PMID 18615560 DOI: 10.1002/Cne.21780 |
0.325 |
|
| 2008 |
Schönemeier B, Schulz S, Hoellt V, Stumm R. Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain. Journal of Neuroimmunology. 198: 39-45. PMID 18513805 DOI: 10.1016/J.Jneuroim.2008.04.010 |
0.305 |
|
| 2008 |
Kolodziej A, Schulz S, Guyon A, Wu DF, Pfeiffer M, Odemis V, Höllt V, Stumm R. Tonic activation of CXC chemokine receptor 4 in immature granule cells supports neurogenesis in the adult dentate gyrus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 4488-500. PMID 18434527 DOI: 10.1523/Jneurosci.4721-07.2008 |
0.33 |
|
| 2008 |
Ginj M, Zhang H, Eisenwiener KP, Wild D, Schulz S, Rink H, Cescato R, Reubi JC, Maecke HR. New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2019-27. PMID 18381940 DOI: 10.1158/1078-0432.Ccr-07-1687 |
0.328 |
|
| 2008 |
Asnacios A, Courbon F, Rochaix P, Bauvin E, Cances-Lauwers V, Susini C, Schulz S, Boneu A, Guimbaud R, Buscail L. Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: New prognostic factors for malignant well-differentiated endocrine tumors Journal of Clinical Oncology. 26: 963-970. PMID 18281671 DOI: 10.1200/Jco.2007.12.7431 |
0.341 |
|
| 2008 |
Plöckinger U, Albrecht S, Mawrin C, Saeger W, Buchfelder M, Petersenn S, Schulz S. Selective loss of somatostatin receptor 2 in octreotide-resistant growth hormone-secreting adenomas. The Journal of Clinical Endocrinology and Metabolism. 93: 1203-10. PMID 18198230 DOI: 10.1210/Jc.2007-1986 |
0.323 |
|
| 2008 |
Unger N, Serdiuk I, Sheu SY, Walz MK, Schulz S, Saeger W, Schmid KW, Mann K, Petersenn S. Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumours Clinical Endocrinology. 68: 850-857. PMID 18031328 DOI: 10.1111/J.1365-2265.2007.03124.X |
0.332 |
|
| 2007 |
Jacobs S, Schulz S. Intracellular trafficking of somatostatin receptors. Molecular and Cellular Endocrinology. 286: 58-62. PMID 18045773 DOI: 10.1016/J.Mce.2007.10.005 |
0.356 |
|
| 2007 |
Christenn M, Kindler S, Schulz S, Buck F, Richter D, Kreienkamp HJ. Interaction of brain somatostatin receptors with the PDZ domains of PSD-95. Febs Letters. 581: 5173-7. PMID 17950729 DOI: 10.1016/J.Febslet.2007.10.003 |
0.336 |
|
| 2007 |
Wu DF, Koch T, Liang YJ, Stumm R, Schulz S, Schröder H, Höllt V. Membrane glycoprotein M6a interacts with the micro-opioid receptor and facilitates receptor endocytosis and recycling. The Journal of Biological Chemistry. 282: 22239-47. PMID 17548356 DOI: 10.1074/Jbc.M700941200 |
0.385 |
|
| 2007 |
Tulipano G, Schulz S. Novel insights in somatostatin receptor physiology European Journal of Endocrinology. 156. PMID 17413186 DOI: 10.1530/Eje.1.02354 |
0.395 |
|
| 2007 |
Palmieri G, Montella L, Aiello C, Barbieri F, Vizio DD, Schulz S, Beninati S, Budillon A, Caraglia M, Insabato L, Florio T. Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract Amino Acids. 32: 395-400. PMID 17279309 DOI: 10.1007/S00726-006-0386-Y |
0.316 |
|
| 2006 |
Schulz S, Stumm R, Höllt V. Immunofluorescent identification of neuropeptide B-containing nerve fibers and terminals in the rat hypothalamus. Neuroscience Letters. 411: 67-71. PMID 17067739 DOI: 10.1016/J.Neulet.2006.10.015 |
0.309 |
|
| 2006 |
Rittner HL, Labuz D, Schaefer M, Mousa SA, Schulz S, Schäfer M, Stein C, Brack A. Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2627-9. PMID 17060402 DOI: 10.1096/Fj.06-6077Fje |
0.31 |
|
| 2006 |
Ginj M, Schmitt JS, Chen J, Waser B, Reubi JC, de Jong M, Schulz S, Maecke HR. Design, synthesis, and biological evaluation of somatostatin-based radiopeptides. Chemistry & Biology. 13: 1081-90. PMID 17052612 DOI: 10.1016/J.Chembiol.2006.08.012 |
0.32 |
|
| 2006 |
Schulz S, Röcken C, Schulz S. Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies. Virchows Archiv : An International Journal of Pathology. 449: 421-7. PMID 16967266 DOI: 10.1007/S00428-006-0265-7 |
0.366 |
|
| 2006 |
Schulz S, Röcken C, Schulz S. Immunocytochemical localisation of plasma membrane GHRH receptors in human tumours using a novel anti-peptide antibody. European Journal of Cancer (Oxford, England : 1990). 42: 2390-6. PMID 16904887 DOI: 10.1016/J.Ejca.2006.03.027 |
0.348 |
|
| 2006 |
Schulz S, Stumm R, Röcken C, Mawrin C, Schulz S. Immunolocalization of full-length NK1 tachykinin receptors in human tumors. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 54: 1015-20. PMID 16651388 DOI: 10.1369/Jhc.6A6966.2006 |
0.357 |
|
| 2006 |
Stumm R, Rüthrich H, Schulz S, Zhou C, Hollt V. Expression of the mu-opioid receptor is induced in dentate gyrus granule cells after focal cerebrocortical ischaemia and stimulation of entorhinal afferents. The European Journal of Neuroscience. 22: 1032-44. PMID 16176345 DOI: 10.1111/J.1460-9568.2005.04296.X |
0.319 |
|
| 2006 |
Unger N, Serdiuk I, Nes Jvd, Schulz S, Wiedemeyer H, Saeger W, Stolke D, Mann K, Petersenn S. Immunohistochemical expression pattern of somatostatin receptor subtypes 1–5 in pituitary tumors of various etiologies Experimental and Clinical Endocrinology & Diabetes. 114. DOI: 10.1055/S-2006-932873 |
0.334 |
|
| 2005 |
Mawrin C, Schulz S, Hellwig-Patyk A, Kirches E, Roessner A, Lendeckel U, Firsching R, Vorwerk CK, Keilhoff G, Dietzmann K, Grimm K, Lindberg G, Gutmann DH, Scheithauer BW, Perry A. Expression and function of somatostatin receptors in peripheral nerve sheath tumors. Journal of Neuropathology and Experimental Neurology. 64: 1080-8. PMID 16319718 DOI: 10.1097/01.Jnen.0000190065.36182.25 |
0.32 |
|
| 2005 |
Schulz S, Röcken C, Mawrin C, Schulz S. Immunohistochemical localization of CCK1 cholecystokinin receptors in normal and neoplastic human tissues. The Journal of Clinical Endocrinology and Metabolism. 90: 6149-55. PMID 16105969 DOI: 10.1210/Jc.2005-0172 |
0.345 |
|
| 2005 |
Ichikawa H, Schulz S, Höllt V, Mo Z, Xiang M, Sugimoto T. Effect of Brn-3a deficiency on primary nociceptors in the trigeminal ganglion Neuroscience Research. 51: 445-451. PMID 15740807 DOI: 10.1016/J.Neures.2004.12.014 |
0.342 |
|
| 2005 |
Meis S, Sosulina L, Schulz S, Höllt V, Pape HC. Mechanisms of somatostatin-evoked responses in neurons of the rat lateral amygdala. The European Journal of Neuroscience. 21: 755-62. PMID 15733093 DOI: 10.1111/J.1460-9568.2005.03922.X |
0.32 |
|
| 2005 |
Koch T, Widera A, Bartzsch K, Schulz S, Brandenburg LO, Wundrack N, Beyer A, Grecksch G, Höllt V. Receptor endocytosis counteracts the development of opioid tolerance. Molecular Pharmacology. 67: 280-7. PMID 15475572 DOI: 10.1124/Mol.104.004994 |
0.332 |
|
| 2005 |
Montella L, Florio T, Aiello C, Barbieri F, Villa V, Schulz S, Insabato L, Palmieri G. Somatostatin receptor expression in stromal tumors of the gastrointestinal tract Journal of Clinical Oncology. 23: 9042-9042. DOI: 10.1200/Jco.2005.23.16_Suppl.9042 |
0.332 |
|
| 2005 |
Unger N, Tourne H, Redmann A, Schulz S, Saeger W, Mann K, Petersenn S. Immunohistochemical expression of somatostatin receptor subtypes in various normal human tissues Experimental and Clinical Endocrinology & Diabetes. 113. DOI: 10.1055/S-2005-862795 |
0.334 |
|
| 2004 |
Schulz S, Röcken C, Mawrin C, Weise W, Höllt V, Schulz S. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies. Clinical Cancer Research. 10: 8235-8242. PMID 15623599 DOI: 10.1158/1078-0432.Ccr-04-0939 |
0.379 |
|
| 2004 |
Stumm RK, Zhou C, Schulz S, Endres M, Kronenberg G, Allen JP, Tulipano G, Höllt V. Somatostatin receptor 2 is activated in cortical neurons and contributes to neurodegeneration after focal ischemia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 11404-15. PMID 15601946 DOI: 10.1523/Jneurosci.3834-04.2004 |
0.34 |
|
| 2004 |
Schulz S, Mayer D, Pfeiffer M, Stumm R, Koch T, Höllt V. Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375. The Embo Journal. 23: 3282-9. PMID 15272312 DOI: 10.1038/Sj.Emboj.7600334 |
0.326 |
|
| 2004 |
Beyer A, Koch T, Schröder H, Schulz S, Höllt V. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. Journal of Neurochemistry. 89: 553-60. PMID 15086512 DOI: 10.1111/J.1471-4159.2004.02340.X |
0.358 |
|
| 2004 |
Tulipano G, Stumm R, Pfeiffer M, Kreienkamp HJ, Höllt V, Schulz S. Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes. The Journal of Biological Chemistry. 279: 21374-82. PMID 15001578 DOI: 10.1074/Jbc.M313522200 |
0.371 |
|
| 2004 |
Mawrin C, Schulz S, Pauli SU, Treuheit T, Diete S, Dietzmann K, Firsching R, Schulz S, Höllt V. Differential expression of sst1, sst2A, and sst3 somatostatin receptor proteins in low-grade and high-grade astrocytomas. Journal of Neuropathology and Experimental Neurology. 63: 13-9. PMID 14748557 DOI: 10.1093/Jnen/63.1.13 |
0.381 |
|
| 2004 |
Koch T, Brandenburg LO, Liang Y, Schulz S, Beyer A, Schröder H, Höllt V. Phospholipase D2 modulates agonist-induced mu-opioid receptor desensitization and resensitization. Journal of Neurochemistry. 88: 680-8. PMID 14720217 DOI: 10.1046/J.1471-4159.2003.02189.X |
0.369 |
|
| 2004 |
Stumm RK, Zhou C, Schulz S, Höllt V. Neuronal types expressing mu- and delta-opioid receptor mRNA in the rat hippocampal formation. The Journal of Comparative Neurology. 469: 107-18. PMID 14689476 DOI: 10.1002/Cne.10997 |
0.304 |
|
| 2003 |
Mundschenk J, Unger N, Schulz S, Höllt V, Schulz S, Steinke R, Lehnert H. Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy. The Journal of Clinical Endocrinology and Metabolism. 88: 5150-7. PMID 14602742 DOI: 10.1210/Jc.2003-030262 |
0.384 |
|
| 2003 |
Pfeiffer M, Kirscht S, Stumm R, Koch T, Wu D, Laugsch M, Schröder H, Höllt V, Schulz S. Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. The Journal of Biological Chemistry. 278: 51630-7. PMID 14532289 DOI: 10.1074/Jbc.M307095200 |
0.362 |
|
| 2003 |
Ichikawa H, Schulz S, Höllt V, Sugimoto T. The somatostatin SST2A receptor in the rat trigeminal ganglion Neuroscience. 120: 807-813. PMID 12895520 DOI: 10.1016/S0306-4522(03)00364-6 |
0.331 |
|
| 2003 |
Hortala M, Ferjoux G, Estival A, Bertrand C, Schulz S, Pradayrol L, Susini C, Clemente F. Inhibitory role of the somatostatin receptor SST2 on the intracrine-regulated cell proliferation induced by the 210-amino acid fibroblast growth factor-2 isoform: implication of JAK2. The Journal of Biological Chemistry. 278: 20574-81. PMID 12665520 DOI: 10.1074/Jbc.M210767200 |
0.314 |
|
| 2002 |
Allen JP, Canty AJ, Schulz S, Humphrey PP, Emson PC, Young HM. Identification of cells expressing somatostatin receptor 2 in the gastrointestinal tract of Sstr2 knockout/lacZ knockin mice. The Journal of Comparative Neurology. 454: 329-40. PMID 12442323 DOI: 10.1002/Cne.10466 |
0.317 |
|
| 2002 |
Pfeiffer M, Koch T, Schröder H, Laugsch M, Höllt V, Schulz S. Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. The Journal of Biological Chemistry. 277: 19762-72. PMID 11896051 DOI: 10.1074/Jbc.M110373200 |
0.386 |
|
| 2002 |
Braun H, Schulz S, Höllt V. Expression changes of somatostatin receptor subtypes sst2A, sst2B, sst3 and sst4 after a cortical contusion trauma in rats. Brain Research. 930: 191-9. PMID 11879809 DOI: 10.1016/S0006-8993(01)03322-4 |
0.305 |
|
| 2002 |
Kulaksiz H, Eissele R, Rössler D, Schulz S, Höllt V, Cetin Y, Arnold R. Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies Gut. 50: 52-60. PMID 11772967 DOI: 10.1136/Gut.50.1.52 |
0.339 |
|
| 2001 |
Becker A, Grecksch G, Kraus J, Peters B, Schroeder H, Schulz S, Höllt V. Loss of locomotor sensitisation in response to morphine in D1 receptor deficient mice Naunyn-Schmiedebergs Archives of Pharmacology. 363: 562-568. PMID 11383718 DOI: 10.1007/S002100100404 |
0.319 |
|
| 2001 |
Koch T, Schulz S, Pfeiffer M, Klutzny M, Schröder H, Kahl E, Höllt V. C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization. The Journal of Biological Chemistry. 276: 31408-14. PMID 11359768 DOI: 10.1074/Jbc.M100305200 |
0.349 |
|
| 2001 |
Pfeiffer M, Koch T, Schröder H, Klutzny M, Kirscht S, Kreienkamp HJ, Höllt V, Schulz S. Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). The Journal of Biological Chemistry. 276: 14027-36. PMID 11134004 DOI: 10.1074/Jbc.M006084200 |
0.373 |
|
| 2001 |
Schulz S, Händel M, Schreff M, Schmidt H, Höllt V. Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies. Journal of Physiology, Paris. 94: 259-64. PMID 11088003 DOI: 10.1016/S0928-4257(00)00212-6 |
0.369 |
|
| 2000 |
Brüggemann I, Schulz S, Wiborny D, Höllt V. Colocalization of the μ-opioid receptor and calcium/calmodulin-dependent kinase II in distinct pain-processing brain regions Molecular Brain Research. 85: 239-250. PMID 11146127 DOI: 10.1016/S0169-328X(00)00265-5 |
0.361 |
|
| 2000 |
Schmidt H, Schulz S, Klutzny M, Koch T, Händel M, Höllt V. Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells. Journal of Neurochemistry. 74: 414-22. PMID 10617147 DOI: 10.1046/J.1471-4159.2000.0740414.X |
0.351 |
|
| 2000 |
Schreff M, Schulz S, Händel M, Keilhoff G, Braun H, Pereira G, Klutzny M, Schmidt H, Wolf G, Höllt V. Distribution, Targeting, and Internalization of the sst4Somatostatin Receptor in Rat Brain The Journal of Neuroscience. 20: 3785-3797. DOI: 10.1523/Jneurosci.20-10-03785.2000 |
0.375 |
|
| 1999 |
Händel M, Schulz S, Stanarius A, Schreff M, Erdtmann-Vourliotis M, Schmidt H, Wolf G, Höllt V. Selective targeting of somatostatin receptor 3 to neuronal cilia Neuroscience. 89: 909-926. PMID 10199624 DOI: 10.1016/S0306-4522(98)00354-6 |
0.368 |
|
| 1999 |
Wolf R, Koch T, Schulz S, Klutzny M, Schröder H, Raulf E, Bühling F, Höllt V. Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat mu opioid receptor. Molecular Pharmacology. 55: 263-8. PMID 9927617 DOI: 10.1124/Mol.55.2.263 |
0.388 |
|
| 1999 |
Braun H, Schulz S, Becker A, Schröder H, Höllt V. Protective effects of cortistatin (CST-14) against kainate-induced neurotoxicity in rat brain. Brain Research. 803: 54-60. PMID 9729275 DOI: 10.1016/S0006-8993(98)00609-X |
0.306 |
|
| 1998 |
Schulz S, Schreff M, Schmidt H, Händel M, Przewlocki R, Höllt V. Immunocytochemical localization of somatostatin receptor sst2A in the rat spinal cord and dorsal root ganglia European Journal of Neuroscience. 10: 3700-3708. PMID 9875349 DOI: 10.1046/J.1460-9568.1998.00386.X |
0.333 |
|
| 1998 |
Schulz S, Höllt V. Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine‐dependent rats in vivo European Journal of Neuroscience. 10: 1196-1201. PMID 9753188 DOI: 10.1046/J.1460-9568.1998.00103.X |
0.322 |
|
| 1998 |
Koch T, Schulz S, Schröder H, Wolf R, Raulf E, Höllt V. Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. The Journal of Biological Chemistry. 273: 13652-7. PMID 9593704 DOI: 10.1074/Jbc.273.22.13652 |
0.381 |
|
| 1997 |
Schulz S, Schreff M, Koch T, Zimprich A, Gramsch C, Elde R, Höllt V. Immunolocalization of two mu-opioid receptor isoforms (MOR1 and MOR1B) in the rat central nervous system Neuroscience. 82: 613-622. PMID 9466465 DOI: 10.1016/S0306-4522(97)00288-1 |
0.353 |
|
| 1996 |
Schulz S, Schreff M, Nüss D, Gramsch C, Höllt V. Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in pain-modulatory brain regions Neuroreport. 7: 3021-3026. PMID 9116232 DOI: 10.1097/00001756-199611250-00045 |
0.305 |
|
| Show low-probability matches. |